Clinical Trials Logo

Clinical Trial Summary

This is a single-center, randomized, double blind, vehicle-controlled phase 2 study of subjects 8 years of age and older with Common Warts (Verruca vulgaris) who desire treatment.


Clinical Trial Description

This is a single-center, randomized, double blind, vehicle-controlled phase-2 study of subjects 8 years of age and older with Common Warts (Verruca vulgaris) who desire treatment. A total of four visits are planned including one baseline and three follow-ups. Screening will be done at Visit 1 (Baseline) and all safety and efficacy measurements will be made at all subsequent visits (Visits 2-4).

The primary objective is to evaluate the efficacy of twice daily-applied ALC-919 vs. vehicle in male and female subjects 8 years of age and older with Common Warts (Verruca vulgaris). The primary outcome measure is complete resolution of lesions at the 12 week visit. Secondary outcome measures will include the change in lesion count at the 12 week visit, improvement in the Global Aesthetic Improvement Scale score at the 12 week visit and the safety and tolerability profile of the treatment arm compared to the vehicle arm at each study visit. The safety will be assessed using clinical cutaneous safety exams that will report scaling, dryness and erythema on a scale of 0-3 (0= absent, 1=mild. 2=moderate, 3=severe). Tolerability will be assessed by having subjects answer the treatment tolerability questions at each visit during the treatment period. The tolerability question will be assessed using a 0-3 scale for itching, burning, and stinging. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02483455
Study type Interventional
Source Veloce BioPharma LLC
Contact
Status Completed
Phase Phase 2
Start date April 2015
Completion date October 2015

See also
  Status Clinical Trial Phase
Recruiting NCT05937672 - Cold Atmospheric Plasma Device Extension Study Phase 3
Completed NCT00328991 - Clinical Trial Evaluating Efficacy of Duct Tape for Treatment of Warts N/A
Recruiting NCT05409365 - Assessment of Squamous Cell Carcinoma antigen2 in Verruca Vulgaris
Completed NCT03487549 - Cantharidin and Occlusion in Verruca Epithelium Phase 2
Completed NCT01084824 - A Trial Examining the Treatment of Common Warts With Combination Liquid Nitrogen (LN2) and Cantharidin N/A
Terminated NCT01609530 - Pulsed 1064nm Nd:YAG in the Treatment of Verruca Vulgaris Versus Conventional Therapy With Liquid Nitrogen Cryotherapy N/A
Recruiting NCT04620785 - Photodynamic Therapy in Treatment of Verrucae N/A
Completed NCT04793529 - Is Involucrin Has a Role in Verruca Vulgaris? A Clinical and Immunohistochemical Study N/A
Recruiting NCT05799157 - Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts Phase 2
Completed NCT05070754 - Cold Atmospheric Plasma Device for Pediatric Molluscum and Verruca Phase 4
Completed NCT02748902 - Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. Phase 1